Diadem Biotherapeutics

Tuning immunity

Torrance, United States · Founded 2019 · $250K raised

Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$250K
Last Round
$250K SeedNov 2019
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Diadem Biotherapeutics is a clinical-stage biotechnology company engineering first-in-class extracellular vesicles to treat cancer and autoimmune conditions. Its proprietary DECOSTAR™ platform uses decorated extracellular vesicles for costimulatory activation or repression of immune receptors, solving the biophysical challenges in agonist signaling and enabling access to validated immunotherapy targets. The company is focused on harnessing the untapped potential of immune cell receptor activation to develop novel biologics for chronic inflammatory diseases and oncology.

Summary

Diadem Biotherapeutics is a Biotech company based in Torrance, United States, founded in 2019. It has raised $250K in total across 1 round, most recently a $250K Seed round in Nov 2019. Investors include IndieBio.

Funding History

SeedSeed RoundNov 2019
$250K

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Diadem Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/diadem-biotherapeutics"><img src="https://indexed.vc/api/badge/company/diadem-biotherapeutics" alt="Diadem Biotherapeutics on Indexed.vc" width="260" height="76" /></a>